当前位置:首页 - 行情中心 - 华兰疫苗(301207) - 财务分析 - 现金流量表

华兰疫苗

(301207)

  

流通市值:103.79亿  总市值:103.86亿
流通股本:6.01亿   总股本:6.01亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金545,178,790.44214,904,356.361,802,151,946.841,295,544,904.55
  收到其他与经营活动有关的现金12,574,162.779,333,385.3930,813,985.518,802,534.8
  经营活动现金流入小计557,752,953.21224,237,741.751,832,965,932.341,314,347,439.35
  购买商品、接受劳务支付的现金73,935,589.2156,756,914.31252,503,004.83214,925,416.84
  支付给职工以及为职工支付的现金50,728,557.3330,260,391.7395,535,970.376,051,796.74
  支付的各项税费14,211,098.111,804,163.47151,496,897.1199,740,296.93
  支付其他与经营活动有关的现金313,099,535.45128,003,898.05865,388,617.62572,985,373.24
  经营活动现金流出小计451,974,780.09226,825,367.561,364,924,489.86963,702,883.75
  经营活动产生的现金流量净额105,778,173.12-2,587,625.81468,041,442.48350,644,555.6
二、投资活动产生的现金流量:
  收回投资收到的现金5,153,077,109.943,448,841,058.2719,343,331,772.1414,670,908,243.12
  取得投资收益收到的现金48,295,924.1236,833,321.3385,234,155.1373,214,675.92
  处置固定资产、无形资产和其他长期资产收回的现金净额-043,00043,000
  投资活动现金流入小计5,201,373,034.063,485,674,379.619,428,608,927.2714,744,165,919.04
  购建固定资产、无形资产和其他长期资产支付的现金4,450,229.592,104,640.7251,595,885.6938,472,061.77
  投资支付的现金4,984,408,615.43,583,226,064.2619,438,092,900.514,739,499,547.5
  投资活动现金流出小计4,988,858,844.993,585,330,704.9819,489,688,786.1914,777,971,609.27
  投资活动产生的现金流量净额212,514,189.07-99,656,325.38-61,079,858.92-33,805,690.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金--16,281,00016,281,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--16,281,00016,281,000
  偿还债务支付的现金300,000,000---
  分配股利、利润或偿付利息支付的现金59,093,339.9530,660,000.01334,316,500.02336,039,833.35
  支付其他与筹资活动有关的现金--106,786,852.51106,786,852.51
  筹资活动现金流出小计359,093,339.9530,660,000.01441,103,352.53442,826,685.86
  筹资活动产生的现金流量净额-359,093,339.95-30,660,000.01-424,822,352.53-426,545,685.86
四、汇率变动对现金及现金等价物的影响170,007.4255,928.01-84,323.07-22,088.97
五、现金及现金等价物净增加额-40,630,970.34-132,848,023.19-17,945,092.04-109,728,909.46
  加:期初现金及现金等价物余额623,035,019.91623,035,019.91640,980,111.95640,980,111.95
  期末现金及现金等价物余额582,404,049.57490,186,996.72623,035,019.91531,251,202.49
补充资料:
  净利润20,797,156.8-205,515,315.75-
  资产减值准备-12,277,453.7-74,225,065.72-
  固定资产和投资性房地产折旧70,079,889.34-139,716,352.2-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧70,079,889.34-139,716,352.2-
  无形资产摊销397,393.71-664,579.5-
  长期待摊费用摊销0-1,669,257.93-
  处置固定资产、无形资产和其他长期资产的损失0-140,144.03-
  固定资产报废损失4,139.15-241,788.14-
  公允价值变动损失-10,279,395.19--24,300,582.77-
  财务费用2,585,223.01-6,040,684.3-
  投资损失-39,067,003.76--76,072,994.64-
  递延所得税-9,595,212.86-8,821,031.26-
  其中:递延所得税资产减少-9,787,104.34-5,241,954.74-
    递延所得税负债增加191,891.48-3,579,076.52-
  存货的减少-159,904,129.76--97,315,504.69-
  经营性应收项目的减少568,098,449.84-884,472,870.07-
  经营性应付项目的增加-279,390,559.53--642,067,069.65-
  其他3,591,465.83--4,340,367.76-
  现金的期末余额582,404,049.57-623,035,019.91-
  减:现金的期初余额623,035,019.91-640,980,111.95-
  加:现金等价物的期末余额0---
  减:现金等价物的期初余额0---
  现金及现金等价物的净增加额-40,630,970.34--17,945,092.04-
公告日期2025-08-282025-04-282025-03-292024-10-30
审计意见(境内)标准无保留意见
TOP↑